Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Barron's Picks And Pans: Canadian Stocks, NCR, Gilead And More
Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold
The Vetr community has upgraded $GILD to 5-Stars. (Vetr)
Related CELG
Agios/Celgene's Leukemia Candidate Positive in Phase I/II
Epizyme Progressing Well on Two Lead Pipeline Candidates
Apple, Biotechs Lead Nasdaq Rebound; 5 More Leaders Are Showing Resilience (Investor's Business Daily)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!